NOVAVAX INC (NVAX) › Capital ExpendituresNOVAVAX INC (NVAX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $745.0K2010: $1.56M2011: $610.0K2012: $4.34M2013: $5.79M2014: $7.27M2015: $18.27M2016: $18.20M2017: $4.19M2018: $1.37M2019: $1.86M2020: $54.62M2021: $57.49M$57.49M2009Capital Expenditures (USD)2021Fiscal YearCapital ExpendituresChange YoY2021$57.49M+5.2%2020$54.62M+2841.4%2019$1.86M+35.3%2018$1.37M-67.2%2017$4.19M-77.0%2016$18.20M-0.4%2015$18.27M+151.3%2014$7.27M+25.6%2013$5.79M+33.3%2012$4.34M+611.6%2011$610.0K-60.8%2010$1.56M+108.9%2009$745.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share